Suppr超能文献

E47的强制表达对Lmo2诱导的T细胞白血病有不同影响。

Enforced expression of E47 has differential effects on Lmo2-induced T-cell leukemias.

作者信息

Goodings Charnise, Tripathi Rati, Cleveland Susan M, Elliott Natalina, Guo Yan, Shyr Yu, Davé Utpal P

机构信息

Departments of Cancer Biology and Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Department of Biostatistics and Center for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, TN, USA.

出版信息

Leuk Res. 2015 Jan;39(1):100-9. doi: 10.1016/j.leukres.2014.11.016. Epub 2014 Nov 29.

Abstract

LIM domain only-2 (LMO2) overexpression in T cells induces leukemia but the molecular mechanism remains to be elucidated. In hematopoietic stem and progenitor cells, Lmo2 is part of a protein complex comprised of class II basic helix loop helix proteins, Tal1and Lyl1. The latter transcription factors heterodimerize with E2A proteins like E47 and Heb to bind E boxes. LMO2 and TAL1 or LYL1 cooperate to induce T-ALL in mouse models, and are concordantly expressed in human T-ALL. Furthermore, LMO2 cooperates with the loss of E2A suggesting that LMO2 functions by creating a deficiency of E2A. In this study, we tested this hypothesis in Lmo2-induced T-ALL cell lines. We transduced these lines with an E47/estrogen receptor fusion construct that could be forced to homodimerize with 4-hydroxytamoxifen. We discovered that forced homodimerization induced growth arrest in 2 of the 4 lines tested. The lines sensitive to E47 homodimerization accumulated in G1 and had reduced S phase entry. We analyzed the transcriptome of a resistant and a sensitive line to discern the E47 targets responsible for the cellular effects. Our results suggest that E47 has diverse effects in T-ALL but that functional deficiency of E47 is not a universal feature of Lmo2-induced T-ALL.

摘要

仅含LIM结构域蛋白2(LMO2)在T细胞中的过表达会诱发白血病,但其分子机制仍有待阐明。在造血干细胞和祖细胞中,Lmo2是由II类碱性螺旋-环-螺旋蛋白Tal1和Lyl1组成的蛋白复合物的一部分。后两种转录因子与E47和Heb等E2A蛋白形成异二聚体以结合E盒。在小鼠模型中,LMO2与TAL1或LYL1协同诱导T细胞急性淋巴细胞白血病(T-ALL),并且在人类T-ALL中一致表达。此外,LMO2与E2A的缺失协同作用,提示LMO2通过造成E2A缺陷发挥作用。在本研究中,我们在Lmo2诱导的T-ALL细胞系中验证了这一假说。我们用一种E47/雌激素受体融合构建体转导这些细胞系,该构建体可被4-羟基他莫昔芬强制同源二聚化。我们发现,强制同源二聚化在4个受试细胞系中的2个中诱导生长停滞。对E47同源二聚化敏感的细胞系在G1期积累,进入S期的细胞减少。我们分析了一个耐药细胞系和一个敏感细胞系的转录组,以识别导致细胞效应的E47靶点。我们的结果提示,E47在T-ALL中有多种作用,但E47功能缺陷并非Lmo2诱导的T-ALL的普遍特征。

相似文献

1
Enforced expression of E47 has differential effects on Lmo2-induced T-cell leukemias.
Leuk Res. 2015 Jan;39(1):100-9. doi: 10.1016/j.leukres.2014.11.016. Epub 2014 Nov 29.
2
A DNA-binding mutant of TAL1 cooperates with LMO2 to cause T cell leukemia in mice.
Oncogene. 2011 Mar 10;30(10):1252-60. doi: 10.1038/onc.2010.495. Epub 2010 Nov 8.
3
Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL.
Blood. 2013 Sep 19;122(12):2093-103. doi: 10.1182/blood-2012-09-458570. Epub 2013 Aug 7.
4
Angiopoietin-2 is a direct transcriptional target of TAL1, LYL1 and LMO2 in endothelial cells.
PLoS One. 2012;7(7):e40484. doi: 10.1371/journal.pone.0040484. Epub 2012 Jul 6.
5
LIM domain only-2 (LMO2) induces T-cell leukemia by two distinct pathways.
PLoS One. 2014 Jan 21;9(1):e85883. doi: 10.1371/journal.pone.0085883. eCollection 2014.
6
LMO2 Oncoprotein Stability in T-Cell Leukemia Requires Direct LDB1 Binding.
Mol Cell Biol. 2015 Nov 23;36(3):488-506. doi: 10.1128/MCB.00901-15. Print 2016 Feb 1.
7
Structure of the leukemia oncogene LMO2: implications for the assembly of a hematopoietic transcription factor complex.
Blood. 2011 Feb 17;117(7):2146-56. doi: 10.1182/blood-2010-07-293357. Epub 2010 Nov 12.
9
Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12.
Proteins. 2008 Mar;70(4):1461-74. doi: 10.1002/prot.21638.

引用本文的文献

1
Multi-modular structure of the gene regulatory network for specification and commitment of murine T cells.
Front Immunol. 2023 Jan 31;14:1108368. doi: 10.3389/fimmu.2023.1108368. eCollection 2023.
2
Experimental glioma with high bHLH expression harbor increased replicative stress and are sensitive toward ATR inhibition.
Neurooncol Adv. 2020 Sep 10;2(1):vdaa115. doi: 10.1093/noajnl/vdaa115. eCollection 2020 Jan-Dec.
3
ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
Hemasphere. 2018 May 11;2(3):e43. doi: 10.1097/HS9.0000000000000043. eCollection 2018 Jun.
5
LMO2 Oncoprotein Stability in T-Cell Leukemia Requires Direct LDB1 Binding.
Mol Cell Biol. 2015 Nov 23;36(3):488-506. doi: 10.1128/MCB.00901-15. Print 2016 Feb 1.
6
Hhex is Required at Multiple Stages of Adult Hematopoietic Stem and Progenitor Cell Differentiation.
Stem Cells. 2015 Aug;33(8):2628-41. doi: 10.1002/stem.2049. Epub 2015 May 27.

本文引用的文献

1
LMO2 induces T-cell leukemia with epigenetic deregulation of CD4.
Exp Hematol. 2014 Jul;42(7):581-93.e5. doi: 10.1016/j.exphem.2014.04.010. Epub 2014 May 2.
2
LIM domain only-2 (LMO2) induces T-cell leukemia by two distinct pathways.
PLoS One. 2014 Jan 21;9(1):e85883. doi: 10.1371/journal.pone.0085883. eCollection 2014.
3
Causal analysis approaches in Ingenuity Pathway Analysis.
Bioinformatics. 2014 Feb 15;30(4):523-30. doi: 10.1093/bioinformatics/btt703. Epub 2013 Dec 13.
4
Differential involvement of E2A-corepressor interactions in distinct leukemogenic pathways.
Nucleic Acids Res. 2014 Jan;42(1):137-52. doi: 10.1093/nar/gkt855. Epub 2013 Sep 24.
5
Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL.
Blood. 2013 Sep 19;122(12):2093-103. doi: 10.1182/blood-2012-09-458570. Epub 2013 Aug 7.
6
Structural basis for LMO2-driven recruitment of the SCL:E47bHLH heterodimer to hematopoietic-specific transcriptional targets.
Cell Rep. 2013 Jul 11;4(1):135-47. doi: 10.1016/j.celrep.2013.06.008. Epub 2013 Jul 3.
8
LIM-domain-only proteins in cancer.
Nat Rev Cancer. 2013 Feb;13(2):111-22. doi: 10.1038/nrc3418. Epub 2013 Jan 10.
10
Targeting nonclassical oncogenes for therapy in T-ALL.
Cancer Cell. 2012 Apr 17;21(4):459-72. doi: 10.1016/j.ccr.2012.02.029.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验